PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer.
This article reviews PD-1/PD-L1 blockade in NSCLC, including completed clinical trials, ongoing studies, future directions, and challenges.
PMID: 27058572 [PubMed - as supplied by publisher]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Hematology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Study